Clinical Trials Browser

Interventional × Advanced Solid Tumours × toripalimab × Clear all

NCT06868199 2025-09-12

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumours